Cirugía de revascularización miocárdica versus angioplastía en el tratamiento de la enfermedad coronaria de tres vasos y tronco de la coronaria izquierda
Author
dc.contributor.author
Olivares R., Gabriel
Author
dc.contributor.author
Veas, Nicolás
Admission date
dc.date.accessioned
2022-04-12T21:43:22Z
Available date
dc.date.available
2022-04-12T21:43:22Z
Publication date
dc.date.issued
2021
Cita de ítem
dc.identifier.citation
Rev. Med. Chile 2021; 149: 1182-1188
es_ES
Identifier
dc.identifier.issn
0034-9887
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/184880
Abstract
dc.description.abstract
Recent randomized controlled trials confirmed the beneficial outcomes with
coronary artery bypass grafting (CABG) compared with percutaneous coronary
intervention (PCI) in patients with severe three-vessel coronary artery and left
main disease. An increased long-term survival after CABG is associated with a
reduction in spontaneous myocardial infarction and repeat revascularization rates.
While PCI treats only flow-limiting lesions, CABG treats the whole coronary
artery, preventing events in the future. Due to different clinical and anatomic
factors affecting the outcomes, the heart team should formulate treatment assignment
recommendations.
es_ES
Lenguage
dc.language.iso
es
es_ES
Publisher
dc.publisher
Soc Medica Santiago
es_ES
Type of license
dc.rights
Attribution-NonCommercial-NoDerivs 3.0 United States
Cirugía de revascularización miocárdica versus angioplastía en el tratamiento de la enfermedad coronaria de tres vasos y tronco de la coronaria izquierda
es_ES
Title in another language
dc.title.alternative
Coronary artery bypass grafting or percutaneous coronary intervention in patients with severe three vessel disease